Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 21.04.2025 1 J Neuroimmunol 1 J Neurol 1 J Neurol Sci 7 Mult Scler 2 Neurology 1 PLoS One 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Neuroimmunol

1. MARQUES RF, Pedrosa DA, Talim N, Lemos JC, et al
   Relapsing-remitting multiple sclerosis as a potential consequence of thalidomide treatment: A case report.
   J Neuroimmunol. 2025;404:578606.
   PubMed         Abstract available
   
   

   
   J Neurol

2. LEAVITT V, Mostert J, Comtois J, Moral E, et al
   Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy.
   J Neurol. 2025;272:338.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

3. KELLY H, Sun R, Elkasaby M, Wang A, et al
   Movement disorders in relapsing and progressive MS: A comprehensive prospective evaluation of a large real-life cohort.
   J Neurol Sci. 2025;472:123468.
   PubMed         Abstract available
   
   

   
   Mult Scler

4. MARRIE RA, Bolton JM, Ling V, Bernstein CN, et al
   Risk factors for incident peripartum mental illness in multiple sclerosis.
   Mult Scler. 2025 Apr 18:13524585251330109. doi: 10.1177/13524585251330109.
   PubMed         Abstract available
   
   
5. MACARON G, Farah N, Charbonneau S, Morrow SA, et al
   Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor.
   Mult Scler. 2025 Apr 18:13524585251334488. doi: 10.1177/13524585251334488.
   PubMed         Abstract available
   
   
6. FADLALLAH Y, Wang Y, Malik MT, Tian F, et al
   Frequency and potential risk factors associated with the development of asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with relapsing-remitting multiple sclerosis.
   Mult Scler. 2025 Apr 17:13524585251331405. doi: 10.1177/13524585251331405.
   PubMed         Abstract available
   
   
7. JENSEN MP, Robles S, Nash MG, May S, et al
   Hypnosis and mindfulness audio recordings for reducing fatigue in individuals with multiple sclerosis: A randomized controlled study.
   Mult Scler. 2025 Apr 17:13524585251329820. doi: 10.1177/13524585251329820.
   PubMed         Abstract available
   
   
8. EL AYOUBI NK, Bal MN, Metri N, El Sammak S, et al
   Slower retinal thinning over a year predicts continuous NEDA status at follow-up in multiple sclerosis: A longitudinal OCT study.
   Mult Scler. 2025 Apr 12:13524585251332499. doi: 10.1177/13524585251332499.
   PubMed         Abstract available
   
   
9. BSTEH G, Hegen H, Albrecht P, Havla J, et al
   Emphasizing complementary in "Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis".
   Mult Scler. 2025 Apr 12:13524585251329800. doi: 10.1177/13524585251329800.
   PubMed        
   
   
10. CHRISTENSEN R, Jolly A, Yam C, Yiannakas MC, et al
    Response to letter to the editor: 'Investigating the complementary value of OCT to MRI in cognitive impairment in relapsing-remitting multiple sclerosis'.
    Mult Scler. 2025 Apr 12:13524585251329787. doi: 10.1177/13524585251329787.
    PubMed        
    
    

    
    Neurology

11. NEWSOME SD, Krzystanek E, Selmaj KW, Dufek M, et al
    Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study.
    Neurology. 2025;104:e213574.
    PubMed         Abstract available
    
    
12. GUINEBRETIERE O, Pierret C, Calonge Q, Januel E, et al
    Updated Multiple Sclerosis Incidence in France, 2011-2021.
    Neurology. 2025;104:e213586.
    PubMed         Abstract available
    
    

    
    PLoS One

13. SCHLAEGER S, Muhlau M, Gilbert G, Vavasour I, et al
    Sensitivity of multi-parametric quantitative magnetic resonance imaging for multiple sclerosis pathology.
    PLoS One. 2025;20:e0318415.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

14. KETATA I, Ellouz E, Ketata A
    Psychoses onset in multiple sclerosis: A systematic review and meta-analysis.
    Rev Neurol (Paris). 2025 Apr 15:S0035-3787(25)00497.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.